Epirubicin Kabi is a cytotoxic antibiotic (anthracycline drug) used for chemotherapy.

ATC-Code: L01DB03


Strength is denoted by disposable cap color.

  • Epirubicin Kabi 50 mg/25 ml
  • Epirubicin Kabi 200 mg/100 ml


Epirubicin is used in the treatment of a range of neoplastic conditions including:

  • Carcinoma of the breast
  • Gastric cancer

When administered intravesically, epirubicin has been shown to be beneficial in the treatment of papillary transitional cell carcinoma of the bladder, carcinoma-insitu of the bladder, intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection.

Product Information

Please note that this product may not be available in all countries due to different registration status.

Additionally, approved indications, contraindications, side effects, warnings and all over product characteristics may differ between countries. Therefore, always the text of the nationally registered and approved product information is binding! Furthermore, country specific regulatory considerations affect the information we can provide on our products.

If you require any information please contact your local organization.